Skip to content
10-Q

Quarterly Report

BioCardia, Inc. BCDA

0001437749-26-017221

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 13, 2026 11.37M sh
Shares Diluted Q1 2026 · Mar 31, 2026 10.81M sh
Shares Diluted Q1 2026 · Mar 31, 2025 4.64M sh
Capex Q1 2026 · Mar 31, 2026 $3K
Capex Q1 2026 · Mar 31, 2025 $0
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$1.66M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$1.62M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $951K
Cash And Equivalents Q1 2026 · Dec 31, 2025 $2.5M
Stockholders Equity Q1 2026 · Mar 31, 2026 −$1.07M
Stockholders Equity Q1 2026 · Dec 31, 2025 $895K
Stockholders Equity Q1 2026 · Mar 31, 2025 −$1.52M
Stockholders Equity Q1 2026 · Dec 31, 2024 $837K
Current Liabilities Q1 2026 · Mar 31, 2026 $2.78M
Current Liabilities Q1 2026 · Dec 31, 2025 $2.43M
Total Liabilities Q1 2026 · Mar 31, 2026 $2.78M
Total Liabilities Q1 2026 · Dec 31, 2025 $2.52M
Current Assets Q1 2026 · Mar 31, 2026 $1.14M
Current Assets Q1 2026 · Dec 31, 2025 $2.73M
Total Assets Q1 2026 · Mar 31, 2026 $1.71M
Total Assets Q1 2026 · Dec 31, 2025 $3.41M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.21
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.59
Eps Basic Q1 2026 · Mar 31, 2026 −$0.21
Eps Basic Q1 2026 · Mar 31, 2025 −$0.59
Sga Expense Q1 2026 · Mar 31, 2026 $1.03M
Sga Expense Q1 2026 · Mar 31, 2025 $1.2M
Rd Expense Q1 2026 · Mar 31, 2026 $1.24M
Rd Expense Q1 2026 · Mar 31, 2025 $1.53M
Net Income Q1 2026 · Mar 31, 2026 −$2.26M
Net Income Q1 2026 · Mar 31, 2025 −$2.71M
Operating Income Q1 2026 · Mar 31, 2026 −$2.27M
Operating Income Q1 2026 · Mar 31, 2025 −$2.73M